CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Grant or award Director acquired 8,747 shares (grant or award)
- 4 Grant or award Director acquired 8,747 shares (grant or award)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 424B2 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 4 Grant or award SVP and CFO acquired 13,300 shares (grant or award)
- 4 Grant or award See Remarks acquired 13,300 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 33,300 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 18 of 80 · 1,585 filings